In patients referred for echocardiography, moderate-to-severe tricuspid regurgitation had a prevalence of 2.8%, with approximately 1 in 8 potentially suitable for percutaneous intervention.
Cross-Sectional
No
A significant unmet clinical need exists for percutaneous tricuspid valve interventions, with 1 in 8 patients with moderate-to-severe TR (2.8% overall prevalence in TTE referrals) being potentially suitable candidates.
Moderate-to-severe tricuspid regurgitation is associated with higher mortality and morbidity yet remains significantly undertreated. The reasons for this are complex but include a higher operative mortality for patients undergoing isolated tricuspid valve surgery. This study sought to determine the prevalence of patients with moderate-to-severe tricuspid regurgitation and identify those who could be potentially suitable for percutaneous tricuspid valve intervention by screening patients referred for transthoracic echocardiography (ECHO) at a tertiary center. Our results showed that the prevalence of moderate-to-severe tricuspid regurgitation in our total ECHO patient population was 2.8%. Of these, approximately 1 in 8 patients with moderate-to-severe tricuspid regurgitation would be potentially suitable for percutaneous intervention, and suggests a large, unmet clinical need in this population.
Teoh et al. (Thu,) conducted a cross-sectional in Moderate-to-severe tricuspid regurgitation. In patients referred for echocardiography, moderate-to-severe tricuspid regurgitation had a prevalence of 2.8%, with approximately 1 in 8 potentially suitable for percutaneous intervention.